More articles from Study protocols

Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial
Christina S. Thornton, Marcus Povitz, Willis H. Tsai, Andrea H. Loewen, Ada Ip-Buting, Tetyana Kendzerska, W. Ward Flemons, Kristin L. Fraser, Patrick J. Hanly, Sachin R. Pendharkar

ERJ Open Research Apr 2022, 8 (2) 00068-2022; DOI: 10.1183/23120541.00068-2022
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J. Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A. Byrnes, Andrew Bush, Stuart R. Dalziel, Richard Beasley

ERJ Open Research Oct 2021, 7 (4) 00271-2021; DOI: 10.1183/23120541.00271-2021
Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale
Zhenyu Liang, Nanshan Zhong, Rongchang Chen, Qianli Ma, Yongchang Sun, Fuqiang Wen, Ruth Tal-Singer, Bruce E. Miller, Julie Yates, Jie Song, Chris Compton, Beulah Ji, Li Wu, Yang Yang, Paul Jones, Jinping Zheng

ERJ Open Research Jul 2021, 7 (3) 00201-2021; DOI: 10.1183/23120541.00201-2021
Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young

ERJ Open Research Apr 2021, 7 (2) 00805-2020; DOI: 10.1183/23120541.00805-2020
Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

ERJ Open Research Apr 2021, 7 (2) 00054-2021; DOI: 10.1183/23120541.00054-2021
BronchUK: protocol for an observational cohort study and biobank in bronchiectasis
Anthony De Soyza, Philip Mawson, Adam T. Hill, Stuart Elborn, Judy M. Bradley, Charles S. Haworth, R. Andres Floto, Robert Wilson, Michael R. Loebinger, Mary Carroll, Megan Crichton, James D. Chalmers, Anita Sullivan, Jeremy Brown, John R. Hurst, Jamie Duckers, Martin Kelly, John Steer, Tim Gatheral, Paul P. Walker, Craig Winstanley, Alistair McGuire, David Denning, Richard McNally

ERJ Open Research Apr 2021, 7 (2) 00775-2020; DOI: 10.1183/23120541.00775-2020
A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
Matthew Northgraves, Judith Cohen, Victoria Allgar, David Currow, Simon Hart, Kelly Hird, Andrew Hodge, Miriam Johnson, Suzanne Mason, Flavia Swan, Ann Hutchinson

ERJ Open Research Jan 2021, 7 (1) 00955-2020; DOI: 10.1183/23120541.00955-2020
Integrating Comprehensive Geriatric Assessment for people with COPD and frailty starting pulmonary rehabilitation: the Breathe Plus feasibility trial protocol
Lisa Jane Brighton, Catherine J. Evans, Morag Farquhar, Katherine Bristowe, Aleksandra Kata, Jade Higman, Margaret Ogden, Claire Nolan, Deokhee Yi, Wei Gao, Maria Koulopoulou, Sharmeen Hasan, Claire J. Steves, William D-C. Man, Matthew Maddocks

ERJ Open Research Jan 2021, 7 (1) 00717-2020; DOI: 10.1183/23120541.00717-2020
An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM 1
Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac

ERJ Open Research Oct 2020, 6 (4) 00395-2020; DOI: 10.1183/23120541.00395-2020
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
David R. Muccino, Alyn H. Morice, Surinder S. Birring, Peter V. Dicpinigaitis, Ian D. Pavord, Christopher Assaid, Huub Jan Kleijn, Azher Hussain, Carmen La Rosa, Lorcan McGarvey, Jaclyn A. Smith

ERJ Open Research Oct 2020, 6 (4) 00284-2020; DOI: 10.1183/23120541.00284-2020

Main menu

User menu

Search

More articles from Study protocols

Pages

Contact us